Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.
Luisa Corrêa de Araujo KouryArnold GanserNancy BerlinerEduardo Magalhaes RegoPublished in: British journal of haematology (2017)
The Latin Americas and Caribbean are regions where social exclusion and inequality persist as the main obstacles to human development and improvement of health conditions, despite economic growth and social development. These countries need to establish international collaborations with the goal of improving health conditions. In this scenario Acute Promyelocytic Leukaemia (APL), a disease with a high cure rate in developed countries and high prevalence in young patients, offers an ideal opportunity to implement measures with educational and cooperative scope. We discuss the experience of Latin America and the Caribbean through a common network, the International Consortium on Acute Promyelocytic Leukaemia (IC-APL).
Keyphrases
- liver failure
- respiratory failure
- healthcare
- mental health
- drug induced
- aortic dissection
- public health
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- hepatitis b virus
- ejection fraction
- risk factors
- health information
- peritoneal dialysis
- risk assessment
- middle aged
- patient reported
- induced pluripotent stem cells